
Monopar Therapeutics Inc.
MNPRHealthcare|Biotechnology|US
$71.42
+4.20 (+6.25%)
DCF Value
$7.99
Tangible Book / Share
$15.32
Cash / Share
$15.72
Next Earnings Report
Nov 12, 2026
EPS est. -$0.82
Financing Filings (last 12 months)
0
No shelf registrations or offering prospectuses filed.
Upcoming Data Readouts (2)
Dec 2026
Est. completion
P1Solid Tumor, Adult
Diagnostic Efficacy and Dosimetry of MNPR-101-DFO*-89Zr in Patients With Solid Tumors
NCT06337084n=12
Jan 2027
Est. completion
Recent Press Releases
Monopar to Present at AASLD – The Liver Meeting® 2026: Phase 3 FoCus Baseline Data and ALXN1840 Molybdenum Safety Data
Nov 2, 2026 · GlobeNewsWire
Monopar Appoints Jeffrey D. Kent, M.D.
Aug 19, 2026 · GlobeNewsWire
Monopar Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates
Aug 12, 2026 · GlobeNewsWire
SEC Filings (73)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Oct 27, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Aug 12, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Aug 12, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Aug 12, 2026 | 8-K | Material event | DocumentIndex |
| Aug 12, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Jul 22, 2026 | S-8 POS | Employee stock plan | DocumentIndex |
| Jul 22, 2026 | S-8 POS | Employee stock plan | DocumentIndex |
| Jul 22, 2026 | S-8 POS | Employee stock plan | DocumentIndex |
| Jul 22, 2026 | S-8 POS | Employee stock plan | DocumentIndex |
| Jul 22, 2026 | S-8 | Employee stock plan | DocumentIndex |
| Jul 22, 2026 | 8-K | Material event | DocumentIndex |
| Jun 30, 2026 | 8-K | Material event | DocumentIndex |
| Jun 26, 2026 | 8-K | Material event | DocumentIndex |
| Jun 23, 2026 | 8-K | Material event | DocumentIndex |
| May 29, 2026 | 8-K | Material event | DocumentIndex |
| May 19, 2026 | 8-K | Material event | DocumentIndex |
| May 15, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| May 14, 2026 | 10-Q | Quarterly report | DocumentIndex |
| May 14, 2026 | 8-K | Material event | DocumentIndex |
| May 13, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Apr 30, 2026 | ARS | Annual report to holders | DocumentIndex |
| Apr 30, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Apr 30, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Apr 20, 2026 | 8-K | Material event | DocumentIndex |
| Apr 1, 2026 | 10-K/A | Annual report | DocumentIndex |
| Mar 27, 2026 | 8-K | Material event | DocumentIndex |
| Mar 27, 2026 | 10-K | Annual report | DocumentIndex |
| Mar 2, 2026 | 8-K | Material event | DocumentIndex |
| Feb 17, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Feb 6, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Jan 30, 2026 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Nov 14, 2025 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Nov 14, 2025 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Nov 13, 2025 | 8-K | Material event | DocumentIndex |
| Nov 13, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Nov 10, 2025 | 8-K | Material event | DocumentIndex |
| Sep 24, 2025 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Sep 24, 2025 | 8-K | Material event | DocumentIndex |
| Sep 24, 2025 | 424B5 | Offering prospectus | DocumentIndex |
| Sep 15, 2025 | 8-K | Material event | DocumentIndex |